VATIS UPDATE Article

Researchers from Karolinska Institutet, Sweden, have identified genetic switches that can be ‘turned off’ to stop the growth of cancer cells, an advance that paves the way for new therapies against the deadly disease. They found that cancer cells and normal cells use different gene switches in order to regulate cell growth. The removal of a large regulatory region linked to different types of cancer caused a dramatic resistance to tumour formation, but did not affect normal cell growth in mice.

“Since we find that the growth of normal and cancer cells is driven by different gene switches, we can in principle aim at switching off the system for growth only in the cancer cells without any harmful effect on the growth of normal cells. This can lead to the development of highly specific approaches for cancer therapy with much lower toxic side effects,” said Jussi Taipale, at Karolinska Institutet.

Researchers analysed a large gene switch region that is linked to the risks of developing many different types of cancer, including prostate, breast, colon, bladder and thyroid cancers as well as chronic lymphocytic leukaemia and myeloma. The variation in this region accounts for far more cancer-related deaths than inherited mutations in well-known cancer-causing genes, researchers said.